Chikungunya vaccine trial for kids pulled before start
NCT ID NCT07133178
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a vaccine called VLA1553 to protect healthy children aged 1 to 11 years from chikungunya, a virus spread by mosquitoes. The plan was to give the vaccine or a comparison shot to over 3,000 children and check for immune responses and safety. However, the trial was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.